What is seres therapeutics? Founded by Flagship Pioneering in 2012, Seres Therapeutics (NASDAQ: MCRB) is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the state of bacterial persity and function is imbalanced.Where is the seres office located? Seres’ offices, research labs and manufacturing facility are in the heart of Cambridge, Mass. SERES THERAPEUTICS, INC. For directions to the Seres office, please click here.Who is the ceo of seres? Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Eric Shaff is the President and Chief Executive Officer of Seres. Mr. Shaff was previously the Executive Vice President, Chief Operating and Financial Officer of Seres.Does seres therapeutics ser 109 work for c diff? CAMBRIDGE, Mass., September 15, 2021--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced it has achieved enrollment of 300 subjects with the ECOSPOR IV open-label study evaluating SER-109, an investigational oral microbiome therapeutic for recurrent C. difficile infection (rCDI).
617-945-9626 Phone Number 617-945-9626 Seres Therapeutics is a microbiome therapeutics company focused on discovering and developing Ecobiotic therapeutic products. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.